ERN ReCONNET

Recent papers from ERN ReCONNET

1. Tear‐based biomarker trajectories associated with uveitis in juvenile idiopathic arthritis: a multicenter prospective studyArthritis Care & Research · 2026
2. Activating variants in PRKD2 in two families with Systemic sclerosis, and enrichment of rare variants in a sporadic series2026
3. Selexipag in SSc-associated pulmonary arterial hypertension: long-term real-world data from a multicentre Italian cohortLara D. Veeken · 2026
4. Caveolin-1 as a Marker of Endothelial Damage in Primary Antiphospholipid Syndrome NephropathyKidney Medicine · 2025
5. Development and validation of a EULAR disease activity score in antiphospholipid syndromeAnnals of the Rheumatic Diseases · 2025
6. Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE surveyTherapeutic Advances in Musculoskeletal Disease · 2025
7. EULAR /American College of Rheumatology Classification Criteria for Pediatric Chronic Nonbacterial OsteomyelitisArthritis & Rheumatology · 2025
8. Developing consensus outcome measures in juvenile systemic sclerosis: a global survey of pediatric rheumatologists and literature reviewPediatric Rheumatology · 2025
9. EULAR/ACR classification criteria for paediatric chronic nonbacterial osteomyelitis (CNO)Annals of the Rheumatic Diseases · 2025
10. Comparison of Lineblot and Immunoprecipitation Methods in the Detection of Myositis-Specific and Myositis-Associated Antibodies in Patients with Idiopathic Inflammatory Myopathies: Consistency with Clinical DiagnosesDiagnostics · 2024
11. Bridging the Diagnostic Gap for Hypermobile Ehlers‐Danlos Syndrome and Hypermobility Spectrum Disorders: Evidence of a Common Extracellular Matrix Fragmentation Pattern in Patient Plasma as a Potential BiomarkerAmerican Journal of Medical Genetics Part A · 2024
12. Interleukin 6 inhibition in refractory antisynthetase syndrome: case-based literature reviewActa Clinica Belgica · 2024
13. Pos1197 Validation of Patient-Reported Outcomes Measurement Information System (Promis) Questionnaires for Children With Chronic Nonbacterial Osteomyelitis Using the Choir DataAnnals of the Rheumatic Diseases · 2024
14. POS0438 DISEASE SUBSET AND DURATION ARE ASSOCIATED WITH INCREASED PATIENT-REPORTED DISEASE BURDEN, MEASURED BY THE EULAR SYSTEMIC ScleroID IMPACT OF DISEASE (SCLEROID) QUESTIONNAIRE, IN AN ITALIAN MONOCENTRIC COHORTAnnals of the Rheumatic Diseases · 2024
15. Pos0902 What Is the Impact of Conflicting Information on the Use of Anti-Rheumatic Drugs in Pregnancy and Breastfeeding? Likelihood for Apprehension and Medication Cessation Reported by Health Care Providers in the Global Praise SurveyAnnals of the Rheumatic Diseases · 2024
16. Op0297 Intra-Renal Involvement in Primary Antiphospholipid Antibodies Syndrome: Data From Two Italian CentersAnnals of the Rheumatic Diseases · 2024
17. Ab1006 Assessment of Qrisk3 as a Predictor of Cardiovascular Disease Risk in Patients With Systemic Lupus ErythematosusAnnals of the Rheumatic Diseases · 2024
18. Pos0846 the Evaluation of Lower Extremities Arterial Disease in Systemic Sclerosis Patients Through Rheumatologist-Vascular Surgeon Multidisciplinary Management: Preliminary Data From an Italian Single Centre StudyAnnals of the Rheumatic Diseases · 2024
19. Setting the bar differently: how to navigate old and new sets of criteria for the classification of antiphospholipid syndromeLara D. Veeken · 2024
20. Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it studyRMD Open · 2024